Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
about
How we read FCH-PET/CT for prostate cancerRadiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.Positron emission tomography (PET) in primary prostate cancer staging and risk assessmentCholine kinase alpha-Putting the ChoK-hold on tumor metabolism.Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.Case: Incidental 18F-fluorodeoxyglucose-positron emission tomography/computed tomography prostate uptake: How should these patients be managed?Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intentA Promising Future for Prostate Cancer Diagnostics.Lymph node imaging in initial staging of prostate cancer: An overview and update.High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.18-Fluoride labeled sodium fluoride positron emission tomography with computer tomography: the impact of pretreatment staging in intermediate- and high-risk prostate cancer.Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicineTroubleshooting for F-18 Fluorocholine Synthesis: An Institutional ExperienceUpcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncologyClinical implications of PET/CT in prostate cancer management
P2860
Q28077447-3307161F-AEE1-4DB7-97BA-DB8908CC84E6Q30395717-4BCF19B0-927F-49FB-9524-A2F165FCE105Q33890153-7E04ADE6-01CF-4642-8796-BCCF9BBA78DEQ35987985-9042AB34-3ED3-42A6-B442-8B76A9812043Q36309665-53278D1F-DA65-4CFE-BC8E-0917FAB52233Q37594922-0F77EC52-BA2D-4B6C-97F9-1226DC2D1BEEQ39041614-3A6F0FB1-C259-4D7D-B220-D50829CB3823Q41073507-A0CB5549-5F78-4A21-B56E-D635DB46DC30Q41829682-91652F35-2204-4584-91B3-BB56DE7D4791Q42370036-61A5E843-6895-4CE6-B8CF-D595489AC9F7Q47157403-ED0D86CF-0ADD-4FDB-96E4-AF5F41C1F3C9Q47277749-7FA0DC07-8D9D-4FF7-AA6F-A40DEA76F35AQ55165433-0334EA57-F6E7-4EC0-8E8B-6417815E672CQ57107703-D3AD34E1-4320-4731-8A86-88CCED736B7FQ58593205-AE8CC602-9437-4C85-954D-316BF4F90E44Q58787312-A7F49E10-1DD1-4532-9F96-59A3B48588E3Q59137133-82578095-BDC9-44FF-8F8B-163461B93A70
P2860
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
@en
type
label
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
@en
prefLabel
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
@en
P2093
P2860
P1476
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
@en
P2093
Christian Pirich
Mohsen Beheshti
Werner Langesteger
Wolfgang Loidl
P2860
P304
P577
2015-01-15T00:00:00Z